RECENT WEBINARS
Accelerating CHO Media Development: From Screening To AI Design
Discover how high-throughput screening, process analytics, and AI-guided modeling can help identify promising CHO media and feed combinations faster and support a more predictive approach.
Evaluating Modular CAR T Manufacturing Workflows
As CAR T manufacturing scales, balancing throughput, flexibility, and cell quality becomes increasingly complex. Explore strategies for improving process control, reducing bottlenecks, and more.
Speed Meets Precision: Accelerating Oncology With Smarter Data
This webinar will explore how oncology sponsors are modernizing data flow, analytics, and cross-functional collaboration to support faster, more informed trial decisions without compromising quality.
Scaling Cell And Gene Therapy Manufacturing
Artificial intelligence is reshaping healthcare. Discover proven strategies for secure, compliant AI adoption, strong data governance, and seamless integration to improve patient outcomes.
Annex 1 In Practice: Turning CCS Into Cleanroom Design
Learn how embedding a contamination control strategy into early facility design mitigates risk, protects product quality, and ensures regulatory compliance.
De-Risking The Path To GMP Manufacturing At Another Organization
Successful tech transfer depends on more than moving a process. Early alignment across process readiness, analytical strategy, governance, and decision-making helps reduce execution risk.
Challenges And Opportunities For MSC Expansion Workflows
Discover how optimizing cell culture platforms and closed systems reduces manufacturing costs, improves media efficiency, and supports scalable stem cell production.
Beyond The Starting Material: A Path To GMP Manufacturing Success
Explore how starting material decisions affect cell therapy development, tech transfer, and GMP readiness, as well as practical guidance for aligning material requirements with manufacturing processes.
Scaling AAV Manufacturing To 1000 L: Strategies For Robust Production
Learn how integrated cell line, media, and process design can support consistent AAV production at larger volumes while maintaining productivity and quality, as well as reducing scale-up risk.
Driving Productivity Across The Antibody Manufacturing Workflow
Learn how integrated upstream and downstream strategies can reduce harvest bottlenecks, improve purification efficiency, and support scalable therapeutic antibody manufacturing.
De-Risking Cell Culture Media Scale-Up For Late-Stage Manufacturing
Explore practical approaches to scaling cell culture media manufacturing, from supply assurance to evolving quality requirements, digital formulation tools, and strategies for controlling costs.
Beyond Breakdowns: Building A Culture Of Proactive Maintenance
Reactive maintenance can drive costly downtime, deviations, and reliability challenges. Learn how proactive maintenance strategies help improve equipment uptime and strengthen compliance.
Building Robust Potency Assays
Robust potency assays depend on reliable biological readouts. Learn how quantitative protein expression analysis can provide sensitive, reproducible measurements of cellular responses.
Enabling The Full Potential Of Process Chromatography
Real-time analytics can provide greater visibility into chromatography performance during scale-up, helping teams monitor purification, maintain critical process parameters and quality attributes.
AI-Readiness In A Regulated World: A Practical Playbook For Life Sciences
Uncover how life science teams build defensible governance, maintain human oversight, and manage regulatory risks when adopting advanced digital tools.
How To Define, Monitor, And Hit Critical Endpoints
Improve UF/DF repeatability by defining clear concentration and diafiltration endpoints, matching them with appropriate measurements, and applying real-time in-line analytics to reduce variability.
Driving Measurable Productivity Gains In CHO Cell Culture
Explore how targeted media supplementation can improve CHO cell culture outcomes, simplify process optimization, and increase productivity across monoclonal antibodies and emerging modalities.
Characterizing Process Performance And Robustness In An End-To-End Cryopreserved Autologous CAR-T/TCR Workflow
A systematic evaluation of an end-to-end cryopreserved CAR-T workflow examines how critical process parameters and unit operation interdependencies affect manufacturing consistency and robustness.
CAR-T For Relapsed/Refractory AML
Explore how CD83-targeted CAR T cells may address a central challenge in AML treatment by suppressing malignant blasts while sparing healthy progenitor cells, with insights into antigen biology.
Take The Turbulence Out Of Your Transfections
Run-to-run AAV titer variability can jeopardize production. Controlling incubation timing, DNA input, and media conditions improves yield and batch consistency.
The Future Of Cell Culture Media Development
Predictive modeling and AI are helping reshape cell culture media. Learn how these approaches can focus experimental efforts, accelerate learning, and support more efficient development decisions.
From Data To Decisions: AI And Multi-Omics For Cell Culture Development
See how combining multi-omics data, AI-enabled analytics, and expertise can reveal the biological drivers of process performance, helping biologics developers identify optimization opportunities.
IRB In Action: A Live Mock Board Review
Experience a live mock IRB review! Watch industry experts evaluate a fictional protocol to uncover insights into board decision-making, master the review process, and improve your future submissions.
How Modular Workflows Are Redefining CAR T Manufacturing
Learn how flexible modular workflows can help manufacturers improve process adaptability, throughput, and control while preserving key CAR T quality attributes, including transduction efficiency.
Rewriting The Code: Advances And Challenges In Pediatric Gene Therapy
This presentation examines pediatric gene therapy and the three platforms now driving clinical progress: AAV vectors, lentiviral vectors, and CRISPR-based gene editing.
Navigating AI Compliance In Life Sciences: FDA Policy Insights For AI Governance
Navigating life sciences AI compliance requires strong governance, expert human oversight, and transparent, low-risk deployment strategies.
When High-Stakes ADC Decisions Can't Wait for More Material or Better Data
Learn how a material-sparing analytical workflow can generate reliable data, reduce dependence on calibration assays, and support faster, more confident candidate evaluation.
Reducing Particulate-Related Batch Risk In Bioprocessing
Increasing scrutiny around particulate contamination is pushing teams to act earlier. Understanding where risks originate and applying proactive strategies can ease challenges across production.
A Closer Look At How Single Use Consumables Drive Cost Per Therapy
Single-use consumables can influence cost per therapy, validation risk, and scalability. Gain a practical perspective on spotting cost and risk signals early before they become barriers later.
Residual DNA Testing Across Biotherapeutics
Residual host cell DNA testing can create bottlenecks. Learn how digital PCR supports more consistent quantification, simpler method deployment, and faster in-process and lot release decisions.